Study to Assess the Compliance of Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost

Trial Profile

Study to Assess the Compliance of Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 May 2017

At a glance

  • Drugs Iloprost (Primary)
  • Indications Embolism and thrombosis; Pulmonary arterial hypertension
  • Focus Therapeutic Use
  • Acronyms COMPHI
  • Sponsors Bayer
  • Most Recent Events

    • 03 May 2017 Status changed from active, no longer recruiting to completed.
    • 12 Jul 2016 Status changed from recruiting to active, no longer recruiting.
    • 31 Jul 2015 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top